Skip to main content

Table 2 Medications considered in estimation of costs for treatment for high blood pressure, hypercholesterolemia, and diabetes

From: Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy

   Cost per day (SCR)
  Dose per day 2004 2005
Daily dose and cost of medications    
Metformin 1.5 g 4.83 0.48
Glibenclamide 10 mg 1.22 0.18
Insulin (2004:standard; 2005: pen) 20 units 3.40 7.72
Rosuvastatin (2004: Atorvastatin) 10 mg 7.81 7.31
Bendrofluazide (D) 2.5 mg 0.04 0.05
Atenolol (BB) 50 mg 0.67 0.21
Amlodipin (CCB) 5 mg 2.74 0.51
Lisinopril (ACEI) 20 mg 4.00 1.89
Valsartan (ARB) 80 mg 8.50 5.82
Combinations for treatment of hypertension (mono-, bi-, tri- or quadri-therapy)    
D in 80% of cases or any of (BB, CCB or ACEI/ARB) in 20% of cases Mono 0.52 0.21
D + any of (BB or CCB or ACEI/ARB) Bi 2.51 0.92
D + BB + any of (CCB +ACEI/ARB) Tri 4.08 1.46
D + BB +CCB + (ACEI/ARB) Quadri 7.45 2.66
Average cost of Lisinopril in 90% cases or Valsartan in 10% of cases (ACEI/ARB)   4.45 2.28
Average cost of either BB or CCB or ACEI/ARB   2.47 0.87
Average cost of either CCB or ACEI/ARB   3.37 1.20
  1. US$1 ~ SCR5